Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 2931985, 9 pages
http://dx.doi.org/10.1155/2016/2931985
Research Article

The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes

1Unit of Metabolic Diseases and Clinical Dietetics, “Alma Mater Studiorum” University of Bologna, 40138 Bologna, Italy
2Diabetes and Metabolism Unit, ASL Turin 5, 10023 Chieri, Italy
3Unit of Internal Medicine, IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy
4Center for Outcomes Research and Clinical Epidemiology (CORE), 65124 Pescara, Italy
5Diabetes Unit, AUSL Romagna, 48121 Ravenna, Italy
6Biomedical Research Institute August Pi Sunyer (IDIBAPS) and Center for Biomedical Research in Diabetes and Associated Metabolic Disorders (CIBERDEM), 08036 Barcelona, Spain
7AMD (Italian Association of Clinical Diabetologists), 00192 Rome, Italy

Received 3 November 2015; Revised 25 January 2016; Accepted 29 February 2016

Academic Editor: Daisuke Koya

Copyright © 2016 Gabriele Forlani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • Wenjie Dai, Ling Ye, Aizhong Liu, Shi Wu Wen, Jing Deng, Xin Wu, and Zhiwei Lai, “Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus,” Medicine, vol. 96, no. 39, pp. e8179, 2017. View at Publisher · View at Google Scholar
  • Zachary Bloomgarden, “Non-alcoholic fatty liver disease and type 2 diabetes: Importance of glycemic control,” Journal of Diabetes, 2017. View at Publisher · View at Google Scholar
  • Fernando Bril, and Kenneth Cusi, “Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action,” Diabetes Care, vol. 40, no. 3, pp. 419–430, 2017. View at Publisher · View at Google Scholar
  • Carlo Bruno Giorda, Gabriele Forlani, Roberta Manti, Arianna Mazzotti, Salvatore De Cosmo, Maria Chiara Rossi, Antonio Nicolucci, Paolo Di Bartolo, Antonio Ceriello, Pietro Guida, Barbara Tartaglino, and Giuseppina Russo, “Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients,” Diabetes Research and Clinical Practice, 2017. View at Publisher · View at Google Scholar
  • Aline Maria Stolf, Cibele Campos Cardoso, and Alexandra Acco, “Effects of Silymarin on Diabetes Mellitus Complications: A Review,” Phytotherapy Research, 2017. View at Publisher · View at Google Scholar
  • Morteza Motedayen, Reza Gholami, Mohsen Norouzinia, Majid Dousti, Fatemeh Sayehmiri, Nasrin Amiri Dash Atan, Mehdi Koushki, and Reza Vafaee, “Type 2 diabetes mellitus and non-alcoholic fatty liver disease: A systematic review and meta-analysis,” Gastroenterology and Hepatology from Bed to Bench, vol. 10, pp. S1–S7, 2017. View at Publisher · View at Google Scholar
  • Josep Franch-Nadal, Llorenç Caballeria, Manel Mata-Cases, Didac Mauricio, Carolina Giraldez-García, José Mancera, Albert Goday, Xavier Mundet-Tudurí, and Enrique Regidor, “Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study,” Plos One, vol. 13, no. 6, pp. e0198327, 2018. View at Publisher · View at Google Scholar
  • Eunju Kim, Jae-Ho Shin, Pu Reum Seok, Min-Soo Kim, Sang-Ho Yoo, and Yuri Kim, “Phyllodulcin, a natural functional sweetener, improves diabetic metabolic changes by regulating hepatic lipogenesis, inflammation, oxidative stress, fibrosis, and gluconeogenesis in db/db mice,” Journal of Functional Foods, vol. 42, pp. 1–11, 2018. View at Publisher · View at Google Scholar
  • Amandeep Singh, Phuc Le, Maajid M. Peerzada, Rocio Lopez, and Naim Alkhouri, “The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients,” Journal of Clinical Gastroenterology, vol. 52, no. 3, pp. 268–272, 2018. View at Publisher · View at Google Scholar
  • Francesco Bifari, Roberto Manfrini, Michele Dei Cas, Cesare Berra, Matteo Siano, Massimo Zuin, Rita Paroni, and Franco Folli, “Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH),” Pharmacological Research, vol. 137, pp. 219–229, 2018. View at Publisher · View at Google Scholar
  • Abdullah Alsabaani, Ahmed Mahfouz, Nabil Awadalla, Mustafa Musa, and Suliman Al Humayed, “Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia,” International Journal of Environmental Research and Public Health, vol. 15, no. 11, pp. 2521, 2018. View at Publisher · View at Google Scholar
  • S. A. Pavlovskyi, and N. G. Virstyuk, “Determination Of Fiber Development Of Liver In Patients With Type 2 Diabetes Mellitus Associated With Non-Alcohol Fatty Liver Disease,” World of Medicine and Biology, vol. 14, no. 63, pp. 061, 2018. View at Publisher · View at Google Scholar
  • Luigi Barrea, Giovanna Muscogiuri, Giuseppe Annunziata, Daniela Laudisio, Giulia de Alteriis, Gian Carlo Tenore, Annamaria Colao, and Silvia Savastano, “A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO),” Nutrients, vol. 11, no. 6, pp. 1310, 2019. View at Publisher · View at Google Scholar
  • Paula Mayo, “Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes: a close and developing relationship,” Gastrointestinal Nursing, vol. 17, no. 2, pp. 30–35, 2019. View at Publisher · View at Google Scholar
  • Sumeet K. Asrani, Harshad Devarbhavi, John Eaton, and Patrick S. Kamath, “Burden of liver diseases in the world,” Journal of Hepatology, vol. 70, no. 1, pp. 151–171, 2019. View at Publisher · View at Google Scholar
  • Cong Wang, Miao He, Jiajia Peng, Shengbing Li, Min Long, Wenwen Chen, Dongfang Liu, Gangyi Yang, and Lili Zhang, “Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus,” Cytokine, vol. 125, pp. 154837, 2020. View at Publisher · View at Google Scholar